Abstract
Aneurysms are the most important disorder that affects the aorta. Aneurysms involving the abdominal aorta are typically associated with atherosclerosis, whereas those involving the thoracic aorta have many causes, including congenital abnormalities in the structure of the aortic wall. This chapter will discuss thoracic aortic aneurysms, such as Marfan syndrome, bicuspid aortic valve, and familial thoracic aortic aneurysm syndrome, and also abdominal aortic aneurysms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected References
Allaire E, Hasenstab D, Kenagy RD, et al. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation 1998;98:249–255.
Aoyoma T, Francke U, Dietz HC, Furthmayr H. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibrob-lasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J Clin Invest 1994;94:130–137.
Biddinger A, Rocklin M, Coselli J, Milewicz DM. Familial thoracic aortic dilatations and dissections: a case control study. J Vasc Surg 1997;25:506–511.
Booms T, Tiecke F, Rosenberg T, Hagemeier C, Robinson PN. Differential effects of FBN1 mutations on in vitro proteolysis of recombinant fibrillin-1 fragments. Hum Genet 2000;107:216–224.
Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997;17:439–444.
Chen J, Kuhlencordt PJ, Astern J, Gyurko R, Huang P. Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein E/endothelial nitric oxide synthase double knockout mice. Circulation 2001;104:2391–2394.
Coady MA, Davis RR, Roberts M, et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999;134:361–367.
Collod G, Babron M, Jondeau G, et al. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet 1994;8:264–268.
Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase in abdominal aortic aneurysms. J Clin Invest 1998;102:1900–1910.
Daugherty A, Cassis LA. Mechanisms of abdominal aortic aneurysm formation. Curr Atheroscler Rep 2002;4(3):222–227.
De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Peyritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62:417–426.
Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991;352:337–339.
Dietz HC, McIntosh I, Sakai LY, et al. Four novel FBN 1 mutations: Significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics 1993;17:468–475.
Eisenberg LM, Markwald RR. Molecular regulation of atrioventricular alvulospetal morphogenesis. Circ Res 1995;77:1–6.
Eldadah ZA, Brenn T, Furthmayr H, Dietz HC. Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J Clin Invest 1995;95:874–880.
Fedak PWM, Verma S, David TE, Leask RL, Weisel RD, Butany J. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002;106:900–904.
Freestone T, Turner RG, Coady A, et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15:1145–1151.
Fukui D, Miyagawa S, Soeda J, Tanaka K, Urayama H, Kawasaki S. Overexpression of transforming growth factor beta1 in smooth muscle cells of human abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2003;25(6):540–545.
Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001;104(4):448–454.
Lee TC, Zhao YD, Courtman DW, et al. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 2000;101:2345–2348.
Loeys B, Nuytinck L, Delvaux I, De Bie S, De Paepe A. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. Arch Intern Med 2001;161:2447–2454.
Milewicz DM, Chen H, Park E-S, et al. Reduced penetrance and variable expressivity of familial thoracic aneurysms/dissections. Am J Cardiol 1998;82:474–479.
Miralles M, Wester W, Sicard GA, Thompson R, Reilly J. Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. J Vasc Surg 1999;29(5):884–893.
Nkomo VT, Enriquez-Sarano M, Ammash NM, et al. Bicuspid aortic valve associated with aortic dilatation. Arterioscler Thromb Vasc Biol 2002;23:351–356.
Pepe G, Giusti B, Atlanasio M, et al. A major involvement in the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene. J Mol Cell Cardiol 1997;29:1877–1884.
Pereira L, Andrikopoulds K, Tian J, et al. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet 1997;17:218–222.
Pereira L, Lee SY, Gayraud B, et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA 1999;96:3819–3823.
Pyeritz RE. The Marfan syndrome. Annu Rev Med 2000;51:481–510.
Pyo R, Lee JK, Shipley M, et al. Targeted gene disruption of metallopro-teinase-9 suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641–1649.
Reinhardt DP, Ono RN, Notbohm H, Muller PK, Bachinger HP, Sakai LY. Mutations in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis: a potential disease causing mechanism in Marfan syndrome. J Biol Chem 2000;275:12,339–12,345.
Robinson PN, Booms P. The molecular pathogenesis of the Marfan syndrome. Cell Mol Life Sci 2001;58:1698–1707.
Robinson PN, Booms P, Katzke S, et al. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fib-rillinopathies. Hum Mutat 2002;20:153–161.
Saito S, Zempo N, Yamashita A, Takenaka H, Fujioka K, Esato K. Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease. Vasc Endovascular Surg 2002;36(1):1–7.
Shah PK. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 1997;96:2115–2117.
Thompson RW, Holmes DR, Mertens RA, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995;96:318–326.
Vaughan CJ, Casey M, He J, et al. Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation 2001;103:2469–2475.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this chapter
Cite this chapter
Das, S., Januzzi, J.L., Isselbacher, E.M. (2006). Aortic Diseases. In: Runge, M.S., Patterson, C. (eds) Principles of Molecular Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-963-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-59259-963-9_13
Publisher Name: Humana Press
Print ISBN: 978-1-58829-202-5
Online ISBN: 978-1-59259-963-9
eBook Packages: MedicineMedicine (R0)